| 21 |
FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy |
2023 |
| 22 |
Prognostic Effect of Nodular and Infiltrating Tumor deposits of colorectal carcinoma and its relation to neoadjuvant therapy a retrospective study |
2023 |
| 23 |
Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma |
2023 |
| 24 |
Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience |
2022 |
| 25 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |
| 26 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |
| 27 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |
| 28 |
Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma |
2021 |
| 29 |
Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
|
2021 |
| 30 |
Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
|
2021 |
